{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,3]],"date-time":"2025-12-03T17:37:17Z","timestamp":1764783437777},"reference-count":31,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2013,4,1]],"date-time":"2013-04-01T00:00:00Z","timestamp":1364774400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["L'Enc\u00e9phale"],"published-print":{"date-parts":[[2013,4]]},"DOI":"10.1016\/j.encep.2012.06.007","type":"journal-article","created":{"date-parts":[[2012,8,24]],"date-time":"2012-08-24T17:30:35Z","timestamp":1345829435000},"page":"143-148","source":"Crossref","is-referenced-by-count":2,"title":["Traitements sp\u00e9cifiques au milieu psychiatrique et thrombogen\u00e8se"],"prefix":"10.1016","volume":"39","author":[{"given":"N.","family":"Khammassi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Chrifi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Hamza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"O.","family":"Cherif","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.encep.2012.06.007_bib0005","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/j.revmed.2008.02.024","article-title":"Risque thromboembolique veineux au cours des affections m\u00e9dicales aigu\u00ebs. Partie 1\u00a0: mod\u00e8les pathog\u00e9niques fondamentaux et cliniques, \u00e9pid\u00e9miologie descriptive et analytique","volume":"29","author":"Le Jeune","year":"2008","journal-title":"Rev Med Interne"},{"key":"10.1016\/j.encep.2012.06.007_bib0010","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.phrs.2008.09.017","article-title":"Use of antipsychotics in elderly patients with dementia: do atypical and conventional agents have a similar safety profile?","volume":"59","author":"Gianluca","year":"2009","journal-title":"Pharmacol Res"},{"issue":"8","key":"10.1016\/j.encep.2012.06.007_bib0015","doi-asserted-by":"crossref","first-page":"685","DOI":"10.2165\/00002018-200831080-00005","article-title":"Associations between venous thromboembolism and antipsychotics. A study of the WHO database of adverse drug reactions","volume":"31","author":"H\u00e4gg","year":"2008","journal-title":"Drug Saf"},{"key":"10.1016\/j.encep.2012.06.007_bib0020","doi-asserted-by":"crossref","first-page":"19","DOI":"10.2147\/CLEP.S4969","article-title":"Antipsychotics and risk of venous thromboembolism: a population-based case-control study","volume":"1","author":"J\u00f6nsson","year":"2009","journal-title":"Clin Epidemiol"},{"issue":"9225","key":"10.1016\/j.encep.2012.06.007_bib0025","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/S0140-6736(05)74502-5","article-title":"Antipsychotic drugs and venous thromboembolism","volume":"356","author":"Thomassen","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.encep.2012.06.007_bib0030","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1192\/bjp.179.1.63","article-title":"Antipsychotic medication and venous thrombosis","volume":"179","author":"Thomassen","year":"2001","journal-title":"BJP"},{"key":"10.1016\/j.encep.2012.06.007_bib0035","first-page":"224","article-title":"Die Thrombosegefahr bei der Chlorpromazin und Reserpine behandlung endogener Psycosen","volume":"30","author":"Grahmann","year":"1959","journal-title":"Nervenartz"},{"key":"10.1016\/j.encep.2012.06.007_bib0040","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S0010-440X(65)80005-0","article-title":"Thromboembolic complications in neuroleptics treatment","volume":"6","author":"Hafner","year":"1965","journal-title":"Compr Psychiatry"},{"key":"10.1016\/j.encep.2012.06.007_bib0045","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1016\/0140-6736(92)93081-W","article-title":"Fatal myocardial infarction and use of psychtropic drugs in young","volume":"340","author":"Thorogood","year":"1992","journal-title":"Lancet"},{"key":"10.1016\/j.encep.2012.06.007_bib0050","first-page":"46","article-title":"Pulmonary thromboembolism associated with olanzapine and risperidone","volume":"69","author":"Borras","year":"2008","journal-title":"J Emerg Med"},{"issue":"9","key":"10.1016\/j.encep.2012.06.007_bib0055","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1253\/circj.68.850","article-title":"Massive pulmonary thromboembolism demonstrated at necropsy in Japanese psychiatric patients treated with neuroleptics including atypical antipsychotics","volume":"68","author":"Hamanaka","year":"2004","journal-title":"Circ J"},{"issue":"5","key":"10.1016\/j.encep.2012.06.007_bib0060","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1097\/YIC.0b013e3282fe9d44","article-title":"Antipsychotics associated with pulmonary embolism in a Swedish medicolegal autopsy series","volume":"23","author":"J\u00f6nsson","year":"2008","journal-title":"Int Clin Psychopharmacol"},{"key":"10.1016\/j.encep.2012.06.007_bib0065","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1253\/circj.67.46","article-title":"Acute massive pulmonary thromboembolism associated with risperidone and conventional phenothizines","volume":"67","author":"Kamijo","year":"2003","journal-title":"Circ J"},{"key":"10.1016\/j.encep.2012.06.007_bib0070","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1016\/S0140-6736(00)02784-7","article-title":"Antipsychotic drug use and risk of first-time idiopathic venous thromboembolism: a case-control study","volume":"356","author":"Zornberg","year":"2000","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.encep.2012.06.007_bib0075","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1517\/14740330903117271","article-title":"Risk of venous thromboembolism due to antipsychotic drug therapy","volume":"8","author":"H\u00e4gg","year":"2009","journal-title":"Expert Opin Drug Saf"},{"issue":"9210","key":"10.1016\/j.encep.2012.06.007_bib0080","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1016\/S0140-6736(00)02066-3","article-title":"Association of venous thromboembolism and clozapine","volume":"355","author":"H\u00e4gg","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.encep.2012.06.007_bib0085","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1176\/appi.ajp.158.3.499","article-title":"Clozapine and pulmonary embolus","volume":"158","author":"Ihde-Scholl","year":"2001","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.encep.2012.06.007_bib0090","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/S0140-6736(05)74504-9","article-title":"Antipsychotic drugs and venous thromboembolism","volume":"356","author":"Knudson","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.encep.2012.06.007_bib0095","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1002\/pds.1424","article-title":"Cardiovascular risks of atypical antipsychotic drug treatment","volume":"16","author":"Drici","year":"2007","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1016\/j.encep.2012.06.007_bib0100","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1097\/00004850-200309000-00008","article-title":"Olanzapine and venous thromboembolism","volume":"18","author":"H\u00e4gg","year":"2003","journal-title":"Int Clin Psychopharmacol"},{"key":"10.1016\/j.encep.2012.06.007_bib0105","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1136\/bmj.327.7428.1384","article-title":"Pulmonary embolism possibly associated with olanzapine treatment","volume":"327","author":"Waage","year":"2003","journal-title":"BMJ"},{"key":"10.1016\/j.encep.2012.06.007_bib0110","doi-asserted-by":"crossref","first-page":"2677","DOI":"10.1001\/archinte.165.22.2677","article-title":"Venous thromboembolism among elderly patients treated with atypical and conventional antipsychotic agents","volume":"165","author":"Liperoti","year":"2005","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.encep.2012.06.007_bib0115","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.jmv.2008.12.157","article-title":"Les traitements par neuroleptiques, un facteur de risque de MTE majeur chez le sujet de moins de 50\u00a0ans\u00a0? \u00c0 propos de donn\u00e9es de l\u2019\u00e9tude Optimev","volume":"34","author":"Bosson","year":"2009","journal-title":"J Mal Vasc"},{"issue":"8","key":"10.1016\/j.encep.2012.06.007_bib0120","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1111\/j.1440-1681.2007.04650.x","article-title":"In vitro effects of antipsychotics on human platelet adhesion and aggregation and plasma coagulation","volume":"34","author":"Axelsson","year":"2007","journal-title":"Clin Pharmacol Physiol"},{"key":"10.1016\/j.encep.2012.06.007_bib0125","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1111\/j.1365-2125.1976.tb00649.x","article-title":"Effects of aspirin and prostaglandin E2\u00a0on secondary phase aggregation responses of schizophrenic patients treated with chlorpromazine","volume":"3","author":"Boullin","year":"1976","journal-title":"Br J Clin Pharmacol"},{"issue":"11","key":"10.1016\/j.encep.2012.06.007_bib0130","doi-asserted-by":"crossref","first-page":"765","DOI":"10.2165\/00023210-200216110-00005","article-title":"Antipsychotic-induced venous thromboembolism: a review of the evidence","volume":"16","author":"H\u00e4gg","year":"2002","journal-title":"CNS Drugs"},{"key":"10.1016\/j.encep.2012.06.007_bib0135","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/j.genhosppsych.2004.06.003","article-title":"Venous thromboembolism and escitalopram","volume":"26","author":"Kurne","year":"2004","journal-title":"Gen Hosp Psychiatry"},{"key":"10.1016\/j.encep.2012.06.007_bib0140","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1080\/01926230601156237","article-title":"Drug-induced thrombosis: experimental, clinical, and mechanistic considerations","volume":"35","author":"Ramot","year":"2007","journal-title":"Toxicol Pathol"},{"key":"10.1016\/j.encep.2012.06.007_bib0145","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1136\/bmj.321.7273.1360","article-title":"Atypical antipsychotics","volume":"321","author":"Kapur","year":"2000","journal-title":"BMJ"},{"key":"10.1016\/j.encep.2012.06.007_bib0150","first-page":"159","article-title":"Case report. Fatal thromboembolic disease: a risk in physically restrained psychiatric patients","volume":"35","author":"Brendan","year":"2008","journal-title":"J Forensic Leg Med"},{"key":"10.1016\/j.encep.2012.06.007_bib0155","doi-asserted-by":"crossref","first-page":"261","DOI":"10.3109\/hrp.8.5.261","article-title":"Seclusion and restraint: a review of recent literature","volume":"8","author":"Busch","year":"2000","journal-title":"Harv Rev Psychiatry"}],"container-title":["L'Enc\u00e9phale"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0013700612001017?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0013700612001017?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,11,21]],"date-time":"2018-11-21T08:01:51Z","timestamp":1542787311000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0013700612001017"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,4]]},"references-count":31,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2013,4]]}},"alternative-id":["S0013700612001017"],"URL":"https:\/\/doi.org\/10.1016\/j.encep.2012.06.007","relation":{},"ISSN":["0013-7006"],"issn-type":[{"value":"0013-7006","type":"print"}],"subject":[],"published":{"date-parts":[[2013,4]]}}}